The stock has gained 7.23% in three sessions to its ruling price, from a close of Rs 290.95 on 13 September 2017.

Meanwhile, the S&P BSE Sensex was up 208.74 points, or 0.65% to 32,481.35. The S&P BSE Small-Cap index was up 175.93 points, or 1.05% to 16,863.69.

More than usual volumes were witnessed on the counter. On the BSE, 28,107 shares were traded in the counter so far, compared with average daily volumes of 4,438 shares in the past one quarter. The stock had hit a high of Rs 322 and a low of Rs 303 so far during the day. The stock hit a 52-week high of Rs 343.90 on 22 May 2017. The stock had hit a 52-week low of Rs 171 on 29 September 2016.

The stock had outperformed the market over the past one month till 15 September 2017, gaining 6.82% compared with the 2.62% gains in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 10.94% as against Sensex's 3.85% gains. The stock had, however, outperformed the market over the past one year, gaining 61.17% compared with the 13.58% gains in the Sensex.

The small-cap company has equity capital of Rs 32.38 crore. Face value per share is Rs 10.

Nucleus Software Exports announced that the Atlas Finance, a micro-finance company in South Africa, has chosen Nucleus Lending Analytics to help them leverage the insights provided by their data to make faster, more informed lending decisions.

Nucleus Software Exports' consolidated net profit fell 43.57% to Rs 11.51 crore on 0.67% rise in net sales to Rs 94.32 crore in Q1 June 2017 over Q4 March 2017.

Nucleus Software Exports is the leading provider of lending and transaction banking products to the global financial services industry.